查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1855935

2025年全球基于次世代定序仪（NGS）的分子诊断市场报告

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基于次世代定序仪（NGS）的分子诊断市场规模呈现强劲成长，从2024年的21亿美元成长到2025年的22.6亿美元，复合年增长率（CAGR）为7.8%。这一增长主要归因于对个性化医疗需求的不断增长、次世代定序仪在临床环境中的广泛应用、临床医生和患者意识的提高、经济高效的NGS平台的日益普及以及无创产前检测应用的不断扩展。

预计未来几年，基于次世代定序仪(NGS) 的分子诊断市场将保持强劲成长，到 2029 年市场规模将达到 30.1 亿美元，复合年增长率 (CAGR) 为 7.4%。预测期内的成长主要受以下因素驱动：对分散式诊断解决方案的需求不断增长、人工智慧在 NGS 数据解读中的应用日益广泛、抗生素抗药性问题日益严峻、监管机构对基于 NGS 的检测方法的支持力度不断加大，以及 NGS 在药物基因组学领域的应用日益普及。预测期内的关键趋势包括：定序准确性的提高、样本製备技术的主导、与药物开发平臺的整合、NGS 在公共卫生监测中的应用，以及疾病特异性NGS 检测组合的开发。

预计未来几年，感染疾病的日益普及将推动基于次世代定序仪（NGS）的分子诊断市场成长。感染疾病是由细菌、病毒、真菌和寄生虫等微生物引起的，这些微生物侵入人体、繁殖并破坏正常功能。全球旅行和人口流动的增加促进了病原体在不同地区和国界之间的传播，从而导致感染疾病病例的增加。基于NGS的分子诊断技术透过对病原体进行全面、精确的分析，并能够同时识别多种微生物，从而缩短诊断时间，提高治疗准确性和患者照护，进而帮助检测这些疾病。例如，英国卫生安全局在2024年2月报告称，英格兰的结核病病例增加了10.7%，从2022年的4380例增加到2023年的4850例。因此，感染疾病的日益普及正在推动对基于NGS的分子诊断技术的需求。

基于新一代定序（NGS）的分子诊断市场的主要参与者正在开发先进产品，例如靶向NGS panel，以提高基因检测的准确性、可及性和效率。这些NGS panel可同时分析特定基因或基因组区域，快速且准确地检测遗传性和体细胞突变。例如，2022年5月，印度医疗设备製造商Genes2Me Pvt. Ltd.推出了一系列全面的NGS panel，旨在用于肿瘤学、个人化医疗和遗传疾病诊断。这些panel涵盖了具有高灵敏度的临床重要基因，并可检测多种基因组改变，包括单核苷酸突变、插入/缺失、拷贝数变异、微卫星不稳定性、融合、致癌性病毒和肿瘤突变负荷。该公司推出的PAN癌症panel靶向约525个基因，仅需50 ng核酸，并支援与主流NGS平台相容的简化工作流程。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球主题关键字：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 终端用户产业分析
  • 全球基于次世代定序仪（NGS）的分子诊断市场：成长率分析
  • 全球基于次世代定序仪（NGS）的分子诊断市场表现：规模与成长，2019-2024年
  • 全球基于次世代定序仪（NGS）的分子诊断市场预测：规模与成长，2024-2029年，2034年预测
  • 全球主题关键字：总潜在市场规模 (TAM)

第六章 市场细分

  • 全球基于次世代定序仪(NGS) 的分子诊断市场：按类型、实际结果和预测（2019-2024 年、2024-2029 年预测、2034 年预测）
  • 装置
  • 试剂和耗材
  • 软体和服务
  • 检测组和检测方法
  • 样品製备试剂盒
  • 全球基于次世代定序仪(NGS) 的分子诊断市场：按应用领域划分，实际结果与预测，2019-2024 年、2024-2029 年预测、2034 年预测
  • 微生物学
  • 感染疾病
  • 肿瘤学
  • 基因检测
  • 其他用途
  • 全球基于次世代定序仪(NGS) 的分子诊断市场：依最终使用者划分，实际值与预测值，2019-2024 年、2024-2029 年预测值、2034 年预测值
  • 研究中心和学术机构
  • 医院和临床检查室
  • 其他最终用户
  • 全球基于次世代定序仪(NGS) 的分子诊断市场：按设备、类型、实际值和预测值细分，2019-2024 年、2024-2029 年预测值、2034 年预测值
  • 桌上型音序器
  • 高通量定序仪
  • 可携式或手持式音序器
  • 临床或诊断定序仪
  • 自动化文库製备系统
  • 数据分析和生物资讯硬体
  • 全球基于次世代定序仪(NGS) 的分子诊断市场：按试剂和耗材、类型细分，实际值和预测值（2019-2024 年、2024-2029 年预测值、2034 年预测值）。
  • 定序试剂和试剂盒
  • 文库製备试剂
  • 靶向序列捕获试剂
  • 扩增试剂
  • 定序流动池和晶片
  • 去氧核糖核酸(DNA) 或核糖核酸 (RNA) 萃取试剂
  • 品管试剂
  • 全球基于次世代定序仪(NGS) 的分子诊断市场：按软体和服务、类型细分，实际值和预测值（2019-2024 年、2024-2029 年预测值、2034 年预测值）。
  • 数据分析软体
  • 生物资讯流程
  • 云端基础的基因组学平台
  • 临床解读工具
  • 资料储存和管理服务
  • 客製化生物资讯学服务
  • 基因组资料库服务
  • 全球基于次世代定序仪(NGS) 的分子诊断市场：按检测组合和检测方法、类型细分，实际值和预测值（2019-2024 年、2024-2029 年预测值、2034 年预测值）。
  • 肿瘤专家组
  • 感染疾病专家组
  • 携带者筛检小组
  • 生殖健康小组
  • 罕见疾病或遗传疾病检测组合
  • 药物基因体学组学分析组
  • 全EXOME或全基因组检测
  • 全球基于次世代定序仪(NGS) 的分子诊断市场：按样本製备试剂盒、类型、实际值和预测值分類的细分市场，2019-2024 年、2024-2029 年预测值、2034 年预测值
  • 去氧核糖核酸(DNA) 萃取试剂盒
  • 核糖核酸（RNA）萃取试剂盒
  • 图书馆准备工具包
  • 标靶富集试剂盒
  • 扩增净化试剂盒
  • 单细胞製备试剂盒
  • 低投入量或劣化样品试剂盒

第七章 区域和国家分析

  • 全球基于次世代定序仪（NGS）的分子诊断市场：区域分析、预测与成长，2019-2024年、2024-2029年预测、2034年预测
  • 全球基于次世代定序仪(NGS) 的分子诊断市场：国家/地区、绩效及预测，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 基于次世代定序仪（NGS）的分子诊断市场：竞争格局
  • 基于次世代定序仪（NGS）的分子诊断市场：公司概况
    • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Amoy Diagnostics Co. Ltd.
  • Tempus Labs Inc.
  • Myriad Genetics Inc.
  • Epigenomics AG
  • Precision for Medicine Inc.
  • Invitae Corporation
  • NeoGenomics Laboratories Inc.
  • Guardant Health Inc.
  • Caris Life Sciences Inc.
  • Foundation Medicine Inc.
  • Oxford Nanopore Technologies Ltd.
  • Freenome Inc.
  • Burning Rock Biotech

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年基于次世代定序仪（NGS）的分子诊断市场：提供新机会的国家
  • 2029年基于次世代定序仪（NGS）的分子诊断市场：提供新机会的细分市场
  • 2029年基于次世代定序仪（NGS）的分子诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38587

Next-generation sequencing (NGS)-based molecular diagnostics is a technology-driven approach that uses high-throughput sequencing to analyze genetic material with precision and speed. It enables detection of genetic variations, mutations, and disease markers at the molecular level, providing detailed insights into the genetic basis of health and disease. This approach supports precise, data-driven diagnostics by combining sequencing technologies with advanced bioinformatics.

The primary types of NGS-based molecular diagnostics include instruments, reagents and consumables, software and services, panels and assays, and sample preparation kits. NGS instruments are the hardware platforms, such as sequencers and automation workstations, used to perform high-throughput DNA/RNA sequencing. Applications include microbiology, infectious diseases, oncology, genetic testing, and other areas. End users include research centers, academic institutions, hospitals, clinical laboratories, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The next-generation sequencing (NGS) based molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides next-generation sequencing (NGS) based molecular diagnostics market statistics, including next-generation sequencing (NGS) based molecular diagnostics industry global market size, regional shares, competitors with a next-generation sequencing (NGS) based molecular diagnostics market share, detailed next-generation sequencing (NGS) based molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing (NGS) based molecular diagnostics industry. The next-generation sequencing (NGS)-based molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation sequencing (NGS)-based molecular diagnostics market size has grown strongly in recent years. It will grow from $2.10 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period is linked to increasing demand for personalized medicine, wider adoption of next-generation sequencing in clinical settings, growing awareness among clinicians and patients, greater availability of cost-effective NGS platforms, and expanding applications in non-invasive prenatal testing.

The next-generation sequencing (NGS)-based molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth projected for the forecast period is driven by rising demand for decentralized diagnostic solutions, increasing use of artificial intelligence in NGS data interpretation, growing burden of antibiotic resistance, enhanced regulatory support for NGS-based tests, and greater utilization of NGS in pharmacogenomics. Primary trends during the forecast period include advancements in sequencing accuracy, technology-driven automation in sample preparation, integration with pharmaceutical development pipelines, incorporation of NGS into public health surveillance, and development of disease-specific NGS panels.

The rising incidence of infectious diseases is expected to drive growth in the next-generation sequencing (NGS)-based molecular diagnostics market in the coming years. Infectious diseases are illnesses caused by microorganisms such as bacteria, viruses, fungi, or parasites that invade and multiply within the body, disrupting normal functions. Increasing global travel and migration contribute to the spread of pathogens across regions and borders, fueling the rise in infectious disease cases. NGS-based molecular diagnostics aids in detecting these diseases by offering comprehensive and precise analysis of pathogens, enabling simultaneous identification of multiple microorganisms, which shortens diagnostic time and improves treatment accuracy and patient care. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing incidence of infectious diseases is propelling the demand for NGS-based molecular diagnostics.

Key players in the NGS-based molecular diagnostics market are developing advanced products such as targeted NGS panels to improve the accuracy, accessibility, and efficiency of genetic testing. These NGS panels analyze specific genes or genomic regions simultaneously to detect hereditary or somatic mutations quickly and accurately. For instance, in May 2022, Genes2Me Pvt. Ltd., an Indian medical equipment manufacturer, introduced a comprehensive series of NGS panels aimed at oncology, personalized medicine, and hereditary disease diagnostics. These panels cover clinically significant genes with high sensitivity and detect various genomic alterations, including single-nucleotide variants, insertions/deletions, copy number variations, microsatellite instability, fusions, oncogenic viruses, and tumor mutation burden. Their PAN cancer panel targets about 525 genes, requiring only 50 ng of nucleic acid, and supports streamlined workflows compatible with major NGS platforms.

In January 2023, QIAGEN NV, a molecular diagnostics and life sciences company based in Germany, acquired Verogen Inc. for an undisclosed sum. This acquisition aims to enhance QIAGEN's leadership in human identification and forensic genomics by integrating Verogen's specialized NGS technologies into its broader molecular diagnostics portfolio. This expansion strengthens QIAGEN's presence in public sector forensics and private sector applications such as genetic genealogy. Verogen Inc. is a US-based company specializing in NGS solutions for forensic genomics.

Major players in the next-generation sequencing (NGS)-based molecular diagnostics market are Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., and TATAA Biocenter AB.

North America was the largest region in the next-generation sequencing (NGS)-based molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next-generation sequencing (NGS)-based molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the next-generation sequencing (NGS)-based molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The next-generation sequencing (NGS)-based molecular diagnostics market includes revenues earned by entities by providing services, such as clinical genomic testing, cancer genomic profiling, infectious disease detection, liquid biopsy testing, and pharmacogenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation sequencing (NGS)-based molecular diagnostics market also includes sales of tumor mutation panels, carrier screening kits, drug response panels, companion diagnostic kits, and whole-genome metagenomics kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next-generation sequencing (ngs)-based molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation sequencing (ngs)-based molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation sequencing (ngs)-based molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Instruments; Reagents And Consumables; Software And Services; Panels And Assays; Sample Preparation Kits
  • 2) By Application: Microbiology; Infectious Diseases; Oncology; Genetic Tests; Other Applications
  • 3) By End User: Research Centers And Academics; Hospitals And Clinical Laboratories; Other End Users
  • Subsegments:
  • 1) By Instruments: Benchtop Sequencers; High-Throughput Sequencers; Portable Or Handheld Sequencers; Clinical Or Diagnostic Sequencers; Automated Library Preparation Systems; Data Analysis And Bioinformatics Hardware
  • 2) By Reagents And Consumables: Sequencing Reagents And Kits; Library Preparation Reagents; Target Enrichment Reagents; Amplification Reagents; Sequencing Flow Cells And Chips; Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents; Quality Control Reagents
  • 3) By Software And Services: Data Analysis Software; Bioinformatics Pipelines; Cloud-Based Genomic Platforms; Clinical Interpretation Tools; Data Storage And Management Services; Custom Bioinformatics Services; Genomic Database Services
  • 4) By Panels And Assays: Oncology Panels; Infectious Disease Panels; Carrier Screening Panels; Reproductive Health Panels; Rare Disease Or Genetic Disorder Panels; Pharmacogenomics Panels; Whole-Exome Or Whole-Genome Assays
  • 5) By Sample Preparation Kits: Deoxyribonucleic Acid (DNA) Extraction Kits; Ribonucleic Acid (RNA) Extraction Kits; Library Preparation Kits; Target Enrichment Kits; Amplification And Cleanup Kits; Single-Cell Preparation Kits; Low-Input Or Degraded Sample Kits
  • Companies Mentioned: Thermo Fisher Scientific; Siemens Healthineers AG; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Amoy Diagnostics Co. Ltd.; Tempus Labs Inc.; Myriad Genetics Inc.; Epigenomics AG; Precision for Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Caris Life Sciences Inc.; Foundation Medicine Inc.; Oxford Nanopore Technologies Ltd.; Freenome Inc.; Burning Rock Biotech; Element Biosciences Inc.; Asuragen Inc.; Bionano Genomics Inc.; Genomic Health Inc.; TATAA Biocenter AB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Characteristics

3. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Trends And Strategies

4. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Growth Rate Analysis
  • 5.4. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Total Addressable Market (TAM)

6. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Segmentation

  • 6.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Consumables
  • Software And Services
  • Panels And Assays
  • Sample Preparation Kits
  • 6.2. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microbiology
  • Infectious Diseases
  • Oncology
  • Genetic Tests
  • Other Applications
  • 6.3. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Centres And Academics
  • Hospitals And Clinical Laboratories
  • Other End Users
  • 6.4. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Benchtop Sequencers
  • High-Throughput Sequencers
  • Portable Or Handheld Sequencers
  • Clinical Or Diagnostic Sequencers
  • Automated Library Preparation Systems
  • Data Analysis And Bioinformatics Hardware
  • 6.5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Reagents And Kits
  • Library Preparation Reagents
  • Target Enrichment Reagents
  • Amplification Reagents
  • Sequencing Flow Cells And Chips
  • Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents
  • Quality Control Reagents
  • 6.6. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Bioinformatics Pipelines
  • Cloud-Based Genomic Platforms
  • Clinical Interpretation Tools
  • Data Storage And Management Services
  • Custom Bioinformatics Services
  • Genomic Database Services
  • 6.7. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology Panels
  • Infectious Disease Panels
  • Carrier Screening Panels
  • Reproductive Health Panels
  • Rare Disease Or Genetic Disorder Panels
  • Pharmacogenomics Panels
  • Whole-Exome Or Whole-Genome Assays
  • 6.8. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA) Extraction Kits
  • Ribonucleic Acid (RNA) Extraction Kits
  • Library Preparation Kits
  • Target Enrichment Kits
  • Amplification And Cleanup Kits
  • Single-Cell Preparation Kits
  • Low-Input Or Degraded Sample Kits

7. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Regional And Country Analysis

  • 7.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 8.1. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 9.1. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 9.2. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 10.1. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 11.1. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 11.2. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 12.1. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 13.1. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 14.1. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 14.2. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 15.1. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 15.2. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 16.1. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 17.1. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 18.1. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 19.1. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 20.1. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 21.1. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 21.2. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 22.1. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 23.1. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 23.2. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 24.1. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 24.2. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 25.1. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 25.2. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 26.1. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 26.2. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 27.1. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 28.1. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 28.2. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 29.1. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 29.2. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Landscape
  • 30.2. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Qiagen N.V.
  • 31.3. Amoy Diagnostics Co. Ltd.
  • 31.4. Tempus Labs Inc.
  • 31.5. Myriad Genetics Inc.
  • 31.6. Epigenomics AG
  • 31.7. Precision for Medicine Inc.
  • 31.8. Invitae Corporation
  • 31.9. NeoGenomics Laboratories Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. Caris Life Sciences Inc.
  • 31.12. Foundation Medicine Inc.
  • 31.13. Oxford Nanopore Technologies Ltd.
  • 31.14. Freenome Inc.
  • 31.15. Burning Rock Biotech

32. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

34. Recent Developments In The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

35. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer